Page last updated: 2024-10-20

phosphorylethanolamine and Atherogenesis

phosphorylethanolamine has been researched along with Atherogenesis in 2 studies

phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ding, L1
Zhang, LY1
Shi, HH1
Wang, CC1
Jiang, XM1
Xue, CH1
Yanagita, T1
Zhang, TT1
Wang, YM1
Singh, SK1
Suresh, MV1
Prayther, DC1
Moorman, JP1
RusiƱol, AE1
Agrawal, A1

Other Studies

2 other studies available for phosphorylethanolamine and Atherogenesis

ArticleYear
Eicosapentaenoic Acid-Enriched Phosphoethanolamine Plasmalogens Alleviated Atherosclerosis by Remodeling Gut Microbiota to Regulate Bile Acid Metabolism in LDLR
    Journal of agricultural and food chemistry, 2020, May-13, Volume: 68, Issue:19

    Topics: Animals; Atherosclerosis; Bile Acids and Salts; Cholesterol 7-alpha-Hydroxylase; Eicosapentaenoic Ac

2020
C-reactive protein-bound enzymatically modified low-density lipoprotein does not transform macrophages into foam cells.
    Journal of immunology (Baltimore, Md. : 1950), 2008, Mar-15, Volume: 180, Issue:6

    Topics: Atherosclerosis; Binding Sites; C-Reactive Protein; Cells, Cultured; Centrifugation, Density Gradien

2008